[DPHARMA] YoY Annual (Unaudited) Result on 31-Dec-2019 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
13-Feb-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
31-Dec-2019 [#4]
Profit Trend
YoY- 16.02%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 696,717 639,175 569,902 576,462 498,722 467,987 312,940 14.26%
PBT 84,851 82,983 76,157 70,809 59,666 51,796 31,479 17.96%
Tax -14,739 -17,300 -17,547 -15,536 -12,025 -9,696 -4,653 21.17%
NP 70,112 65,683 58,610 55,273 47,641 42,100 26,826 17.35%
-
NP to SH 70,112 65,683 58,610 55,273 47,641 42,492 27,115 17.14%
-
Tax Rate 17.37% 20.85% 23.04% 21.94% 20.15% 18.72% 14.78% -
Total Cost 626,605 573,492 511,292 521,189 451,081 425,887 286,114 13.95%
-
Net Worth 657,045 621,564 642,484 525,364 483,173 479,809 454,703 6.32%
Dividend
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Div 21,901 21,660 45,891 40,937 36,403 23,711 18,132 3.19%
Div Payout % 31.24% 32.98% 78.30% 74.06% 76.41% 55.80% 66.87% -
Equity
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Net Worth 657,045 621,564 642,484 525,364 483,173 479,809 454,703 6.32%
NOSH 952,239 941,765 706,026 684,383 661,881 278,959 278,959 22.69%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 10.06% 10.28% 10.28% 9.59% 9.55% 9.00% 8.57% -
ROE 10.67% 10.57% 9.12% 10.52% 9.86% 8.86% 5.96% -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
RPS 73.17 67.87 80.72 84.49 75.35 167.76 112.18 -6.87%
EPS 7.39 6.98 8.46 8.25 7.26 15.09 9.62 -4.29%
DPS 2.30 2.30 6.50 6.00 5.50 8.50 6.50 -15.89%
NAPS 0.69 0.66 0.91 0.77 0.73 1.72 1.63 -13.34%
Adjusted Per Share Value based on latest NOSH - 684,383
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
RPS 72.37 66.40 59.20 59.88 51.81 48.61 32.51 14.26%
EPS 7.28 6.82 6.09 5.74 4.95 4.41 2.82 17.11%
DPS 2.28 2.25 4.77 4.25 3.78 2.46 1.88 3.26%
NAPS 0.6825 0.6457 0.6674 0.5457 0.5019 0.4984 0.4723 6.32%
Price Multiplier on Financial Quarter End Date
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Date 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 -
Price 1.61 1.68 3.38 1.42 0.95 2.53 1.98 -
P/RPS 2.20 2.48 4.19 1.68 1.26 1.51 1.76 3.78%
P/EPS 21.87 24.09 40.72 17.53 13.20 16.61 20.37 1.19%
EY 4.57 4.15 2.46 5.70 7.58 6.02 4.91 -1.18%
DY 1.43 1.37 1.92 4.23 5.79 3.36 3.28 -12.91%
P/NAPS 2.33 2.55 3.71 1.84 1.30 1.47 1.21 11.53%
Price Multiplier on Announcement Date
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Date 23/02/23 15/02/22 22/02/21 13/02/20 18/02/19 28/02/18 24/02/17 -
Price 1.65 1.60 3.42 1.64 1.03 2.97 2.23 -
P/RPS 2.26 2.36 4.24 1.94 1.37 1.77 1.99 2.14%
P/EPS 22.41 22.94 41.20 20.24 14.31 19.50 22.94 -0.38%
EY 4.46 4.36 2.43 4.94 6.99 5.13 4.36 0.37%
DY 1.39 1.44 1.90 3.66 5.34 2.86 2.91 -11.58%
P/NAPS 2.39 2.42 3.76 2.13 1.41 1.73 1.37 9.71%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment